
|Poll|October 15, 2019
Mini Quiz: Antipsychotic Polypharmacy
Author(s)Jose M. Rubio, MD
Listen
0:00 / 0:00
Key Takeaways
- Randomized controlled trials assess polypharmacy's efficacy in managing psychoses' diverse symptom domains, comparing it to monotherapy approaches.
- The trials aim to optimize treatment strategies by evaluating the benefits and risks of combining multiple medications.
Which treatments have proven to be efficacious in meta-analyses as augmentation of clozapine in reducing positive symptoms of schizophrenia? The answer might surprise you.
Advertisement
Hundreds of randomized controlled trials have been conducted to test the efficacy of the multiple forms of polypharmacy in various symptom domains of psychoses.
Which of the following has proven to be efficacious in meta-analyses as augmentation of clozapine in reducing positive symptoms?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
New 6-Month Data From Second Phase 3 Trial Confirms Rapid Effect of COMP360 for TRD
2
Treating Cannabis Addiction and Withdrawal: Latest Clinical Data
3
Phase 2 Trial Initiated for Briumvi for Treatment-Resistant Schizophrenia
4
The Biggest Challenge in Treating Alzheimer Disease: A Conversation With Oleg Tcheremissine, MD
5











